Jeremy Luban - Publications

Columbia University, New York, NY 
Retrovirus, HIV-1, cancer

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lascano J, Uchil P, Mothes W, Luban J. TRIM5 retroviral restriction activity correlates with the ability to induce innate immune signaling. Journal of Virology. PMID 26468522 DOI: 10.1128/JVI.02496-15  0.92
2015 Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature. 526: 212-7. PMID 26416734 DOI: 10.1038/nature15399  0.92
2015 Bilbao A, Zhang Y, Varesio E, Luban J, Strambio-De-Castilla C, Lisacek F, Hopfgartner G. Ranking Fragment Ions Based on Outlier Detection for Improved Label-Free Quantification in Data-Independent Acquisition LC-MS/MS. Journal of Proteome Research. PMID 26412574 DOI: 10.1021/acs.jproteome.5b00394  0.92
2015 Zhang Y, Bilbao A, Bruderer T, Luban J, Strambio-De-Castillia C, Lisacek F, Hopfgartner G, Varesio E. The Use of Variable Q1 Isolation Windows Improves Selectivity in LC-SWATH-MS Acquisition. Journal of Proteome Research. 14: 4359-71. PMID 26302369 DOI: 10.1021/acs.jproteome.5b00543  0.92
2015 Pizzato M, McCauley SM, Neagu MR, Pertel T, Firrito C, Ziglio S, Dauphin A, Zufferey M, Berthoux L, Luban J. Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration. Plos Pathogens. 11: e1005050. PMID 26181333 DOI: 10.1371/journal.ppat.1005050  0.92
2015 Zhang Y, Bottinelli D, Lisacek F, Luban J, Strambio-De-Castillia C, Varesio E, Hopfgartner G. Optimization of human dendritic cell sample preparation for mass spectrometry-based proteomic studies. Analytical Biochemistry. 484: 40-50. PMID 25983236 DOI: 10.1016/j.ab.2015.05.007  0.92
2015 Bilbao A, Varesio E, Luban J, Strambio-De-Castillia C, Hopfgartner G, Müller M, Lisacek F. Processing strategies and software solutions for data-independent acquisition in mass spectrometry. Proteomics. 15: 964-80. PMID 25430050 DOI: 10.1002/pmic.201400323  0.92
2015 Fletcher AJ, Mallery DL, Watkinson RE, Dickson CF, James LC, Luban J. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21 Proceedings of the National Academy of Sciences of the United States of America. 112: 10014-10019. DOI: 10.1073/pnas.1507534112  0.92
2014 Bartels H, Luban J. Gammaretroviral pol sequences act in cis to direct polysome loading and NXF1/NXT-dependent protein production by gag-encoded RNA. Retrovirology. 11: 73. PMID 25212909 DOI: 10.1186/s12977-014-0073-0  0.92
2014 Reinhard C, Bottinelli D, Kim B, Luban J. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration. Retrovirology. 11: 12. PMID 24485168 DOI: 10.1186/1742-4690-11-12  0.92
2014 De Iaco A, Luban J. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology. 11: 11. PMID 24479545 DOI: 10.1186/1742-4690-11-11  0.92
2014 Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, Luban J, Kasprowicz V, Dheda K, Abdool Karim SS, Ndung'u T. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. Journal of Virology. 88: 4291-303. PMID 24478420 DOI: 10.1128/JVI.03603-13  0.92
2014 Yang Y, Luban J, Diaz-Griffero F. The fate of HIV-1 capsid: a biochemical assay for HIV-1 uncoating. Methods in Molecular Biology (Clifton, N.J.). 1087: 29-36. PMID 24158811 DOI: 10.1007/978-1-62703-670-2_3  0.92
2013 Brehm MA, Shultz LD, Luban J, Greiner DL. Overcoming current limitations in humanized mouse research. The Journal of Infectious Diseases. 208: S125-30. PMID 24151318 DOI: 10.1093/infdis/jit319  0.92
2013 Xu H, Franks T, Gibson G, Huber K, Rahm N, De Castillia CS, Luban J, Aiken C, Watkins S, Sluis-Cremer N, Ambrose Z. Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology. 10: 70. PMID 23835323 DOI: 10.1186/1742-4690-10-70  0.92
2013 De Iaco A, Santoni F, Vannier A, Guipponi M, Antonarakis S, Luban J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology. 10: 20. PMID 23414560 DOI: 10.1186/1742-4690-10-20  0.92
2013 Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, Mothes W. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. Journal of Virology. 87: 257-72. PMID 23077300 DOI: 10.1128/JVI.01804-12  0.92
2012 Santoni FA, Guerra J, Luban J. HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency. Retrovirology. 9: 111. PMID 23253934 DOI: 10.1186/1742-4690-9-111  0.92
2012 Luban J. More than one way to TRIM a capsid. Proceedings of the National Academy of Sciences of the United States of America. 109: 19517-8. PMID 23150592 DOI: 10.1073/pnas.1217596109  0.92
2012 Miyamoto T, Nakayama EE, Yokoyama M, Ibe S, Takehara S, Kono K, Yokomaku Y, Pizzato M, Luban J, Sugiura W, Sato H, Shioda T. The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. Plos One. 7: e47757. PMID 23094081 DOI: 10.1371/journal.pone.0047757  0.92
2012 Luban J. Innate immune sensing of HIV-1 by dendritic cells. Cell Host & Microbe. 12: 408-18. PMID 23084911 DOI: 10.1016/j.chom.2012.10.002  0.92
2012 Grütter MG, Luban J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Current Opinion in Virology. 2: 142-50. PMID 22482711 DOI: 10.1016/j.coviro.2012.02.003  0.92
2011 Lai RP, Yan J, Heeney J, McClure MO, Göttlinger H, Luban J, Pizzato M. Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. Plos Pathogens. 7: e1002442. PMID 22194689 DOI: 10.1371/journal.ppat.1002442  0.92
2011 De Iaco A, Luban J. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology. 8: 98. PMID 22145813 DOI: 10.1186/1742-4690-8-98  0.92
2011 Lukic Z, Hausmann S, Sebastian S, Rucci J, Sastri J, Robia SL, Luban J, Campbell EM. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology. 8: 93. PMID 22078707 DOI: 10.1186/1742-4690-8-93  0.92
2011 Pertel T, Reinhard C, Luban J. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology. 8: 49. PMID 21696578 DOI: 10.1186/1742-4690-8-49  0.92
2011 Pertel T, Hausmann S, Morger D, Züger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, ... ... Luban J, et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature. 472: 361-5. PMID 21512573 DOI: 10.1038/nature09976  0.92
2011 Kajaste-Rudnitski A, Marelli SS, Pultrone C, Pertel T, Uchil PD, Mechti N, Mothes W, Poli G, Luban J, Vicenzi E. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. Journal of Virology. 85: 5183-96. PMID 21345949 DOI: 10.1128/JVI.02302-10  0.92
2011 Singh R, Gaiha G, Werner L, McKim K, Mlisana K, Luban J, Walker BD, Karim SS, Brass AL, Ndung'u T. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. Journal of Virology. 85: 208-16. PMID 20980524 DOI: 10.1128/JVI.01810-10  0.92
2010 Santoni FA, Hartley O, Luban J. Deciphering the code for retroviral integration target site selection. Plos Computational Biology. 6: e1001008. PMID 21124862 DOI: 10.1371/journal.pcbi.1001008  0.92
2010 Suñé G, Sarró E, Puigmulé M, López-Hellín J, Zufferey M, Pertel T, Luban J, Meseguer A. Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidney. Plos One. 5: e13930. PMID 21085665 DOI: 10.1371/journal.pone.0013930  0.92
2010 Bernasconi R, Soldà T, Galli C, Pertel T, Luban J, Molinari M. Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradation. Plos One. 5. PMID 20927389 DOI: 10.1371/journal.pone.0013008  0.92
2010 O'Connor C, Pertel T, Gray S, Robia SL, Bakowska JC, Luban J, Campbell EM. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. Journal of Virology. 84: 5997-6006. PMID 20357094 DOI: 10.1128/JVI.02412-09  0.92
2010 Sokolskaja E, Olivari S, Zufferey M, Strambio-De-Castillia C, Pizzato M, Luban J. Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. Journal of Virology. 84: 4851-5. PMID 20181694 DOI: 10.1128/JVI.01699-09  0.92
2009 van Anken E, Pena F, Hafkemeijer N, Christis C, Romijn EP, Grauschopf U, Oorschot VM, Pertel T, Engels S, Ora A, Lástun V, Glockshuber R, Klumperman J, Heck AJ, Luban J, et al. Efficient IgM assembly and secretion require the plasma cell induced endoplasmic reticulum protein pERp1. Proceedings of the National Academy of Sciences of the United States of America. 106: 17019-24. PMID 19805154 DOI: 10.1073/pnas.0903036106  0.92
2009 Strebel K, Luban J, Jeang KT. Human cellular restriction factors that target HIV-1 replication. Bmc Medicine. 7: 48. PMID 19758442 DOI: 10.1186/1741-7015-7-48  0.92
2009 Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grütter C, Martinetti G, Mazzucchelli L, Grütter M, Manz MG, Luban J. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. The Journal of Clinical Investigation. 119: 3035-47. PMID 19741300 DOI: 10.1172/JCI39354  0.92
2009 Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. Plos Pathogens. 5: e1000574. PMID 19730691 DOI: 10.1371/journal.ppat.1000574  0.92
2009 Kaul A, Stauffer S, Berger C, Pertel T, Schmitt J, Kallis S, Zayas M, Lopez MZ, Lohmann V, Luban J, Bartenschlager R. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. Plos Pathogens. 5: e1000546. PMID 19680534 DOI: 10.1371/journal.ppat.1000546  0.92
2009 Marq JB, Hausmann S, Luban J, Kolakofsky D, Garcin D. The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta. The Journal of Biological Chemistry. 284: 25471-8. PMID 19584049 DOI: 10.1074/jbc.M109.018895  0.92
2009 Sebastian S, Grütter C, Strambio de Castillia C, Pertel T, Olivari S, Grütter MG, Luban J. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding. Journal of Virology. 83: 3365-73. PMID 19153241 DOI: 10.1128/JVI.00432-08  0.92
2009 Pertel T, Neagu MR, Hausman S, Zufferey M, Uchil P, Mothes W, Luban J. TRIM5alpha contributes to the anti-viral state Retrovirology. 6: O6.  0.92
2008 Goujon C, Arfi V, Pertel T, Luban J, Lienard J, Rigal D, Darlix JL, Cimarelli A. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. Journal of Virology. 82: 12335-45. PMID 18829761 DOI: 10.1128/JVI.01181-08  0.92
2008 Luban J. HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integrase. Current Biology : Cb. 18: R710-3. PMID 18727908 DOI: 10.1016/j.cub.2008.07.037  0.92
2008 Santoni de Sio FR, Gritti A, Cascio P, Neri M, Sampaolesi M, Galli C, Luban J, Naldini L. Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. Stem Cells (Dayton, Ohio). 26: 2142-52. PMID 18483423 DOI: 10.1634/stemcells.2007-0705  0.92
2008 Bernasconi R, Pertel T, Luban J, Molinari M. A dual task for the Xbp1-responsive OS-9 variants in the mammalian endoplasmic reticulum: inhibiting secretion of misfolded protein conformers and enhancing their disposal. The Journal of Biological Chemistry. 283: 16446-54. PMID 18417469 DOI: 10.1074/jbc.M802272200  0.92
2007 Zhu C, Wang X, Deinum J, Huang Z, Gao J, Modjtahedi N, Neagu MR, Nilsson M, Eriksson PS, Hagberg H, Luban J, Kroemer G, Blomgren K. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. The Journal of Experimental Medicine. 204: 1741-8. PMID 17635954 DOI: 10.1084/jem.20070193  0.92
2007 Takeuchi H, Buckler-White A, Goila-Gaur R, Miyagi E, Khan MA, Opi S, Kao S, Sokolskaja E, Pertel T, Luban J, Strebel K. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells. Journal of Virology. 81: 8080-90. PMID 17522232 DOI: 10.1128/JVI.02727-06  0.92
2007 Berthoux L, Sebastian S, Muesing MA, Luban J. The role of lysine 186 in HIV-1 integrase multimerization. Virology. 364: 227-36. PMID 17397894 DOI: 10.1016/j.virol.2007.02.029  0.92
2007 Sebastian S, Luban J. The retroviral restriction factor TRIM5alpha. Current Infectious Disease Reports. 9: 167-73. PMID 17324355  0.92
2007 Luban J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. Journal of Virology. 81: 1054-61. PMID 16956947 DOI: 10.1128/JVI.01519-06  0.92
2007 Sebastian S, Luban J. The retroviral restriction factor TRIM5α Current Infectious Disease Reports. 9: 167-173. DOI: 10.1007/s11908-007-0013-4  0.92
2006 Zhang S, Joseph G, Pollok K, Berthoux L, Sastry L, Luban J, Cornetta K. G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 546-54. PMID 16901758 DOI: 10.1016/j.ymthe.2006.05.022  0.92
2006 Sokolskaja E, Luban J. Cyclophilin, TRIM5, and innate immunity to HIV-1. Current Opinion in Microbiology. 9: 404-8. PMID 16815734 DOI: 10.1016/j.mib.2006.06.011  0.92
2006 Sokolskaja E, Berthoux L, Luban J. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. Journal of Virology. 80: 2855-62. PMID 16501094 DOI: 10.1128/JVI.80.6.2855-2862.2006  0.92
2006 Sebastian S, Sokolskaja E, Luban J. Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner. Journal of Virology. 80: 2051-4. PMID 16439561 DOI: 10.1128/JVI.80.4.2051-2054.2006  0.92
2005 Berthoux L, Sebastian S, Sokolskaja E, Luban J. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 14849-53. PMID 16203999 DOI: 10.1073/pnas.0505659102  0.92
2005 Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. The Journal of Clinical Investigation. 115: 2904-13. PMID 16167085 DOI: 10.1172/JCI23961  0.92
2005 Sebastian S, Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology. 2: 40. PMID 15967037 DOI: 10.1186/1742-4690-2-40  0.92
2005 Berthoux L, Sebastian S, Sayah DM, Luban J. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues. Journal of Virology. 79: 7883-8. PMID 15919943 DOI: 10.1128/JVI.79.12.7883-7888.2005  0.92
2005 Colgan J, Asmal M, Yu B, Luban J. Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine. Journal of Immunology (Baltimore, Md. : 1950). 174: 6030-8. PMID 15879096  0.92
2005 Gurer C, Höglund A, Höglund S, Luban J. ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity. Journal of Virology. 79: 5557-67. PMID 15827170 DOI: 10.1128/JVI.79.9.5557-5567.2005  0.92
2005 Gurer C, Berthoux L, Luban J. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. Journal of Virology. 79: 910-7. PMID 15613319 DOI: 10.1128/JVI.79.2.910-917.2005  0.92
2004 Sokolskaja E, Sayah DM, Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. Journal of Virology. 78: 12800-8. PMID 15542632 DOI: 10.1128/JVI.78.23.12800-12808.2004  0.92
2004 Sayah DM, Luban J. Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection. Journal of Virology. 78: 12066-70. PMID 15479848 DOI: 10.1128/JVI.78.21.12066-12070.2004  0.92
2004 Berthoux L, Sebastian S, Sokolskaja E, Luban J. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. Journal of Virology. 78: 11739-50. PMID 15479815 DOI: 10.1128/JVI.78.21.11739-11750.2004  0.92
2004 Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, Luban J. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity. 21: 189-201. PMID 15308100 DOI: 10.1016/j.immuni.2004.07.005  0.92
2004 Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 430: 569-73. PMID 15243629 DOI: 10.1038/nature02777  0.92
2004 Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, Schmidt AM, Stern D, Herold KC. Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. Journal of Immunology (Baltimore, Md. : 1950). 173: 1399-405. PMID 15240736  0.92
2004 Chang F, Re F, Sebastian S, Sazer S, Luban J. HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. Molecular Biology of the Cell. 15: 1793-801. PMID 14767062 DOI: 10.1091/mbc.E03-09-0691  0.92
2004 Candé C, Vahsen N, Kouranti I, Schmitt E, Daugas E, Spahr C, Luban J, Kroemer RT, Giordanetto F, Garrido C, Penninger JM, Kroemer G. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis Oncogene. 23: 1514-1521. PMID 14716299 DOI: 10.1038/sj.onc.1207279  0.92
2003 Asmal M, Colgan J, Naef F, Yu B, Lee Y, Magnasco M, Luban J. Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. Immunity. 19: 535-48. PMID 14563318 DOI: 10.1016/S1074-7613(03)00268-1  0.92
2003 Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nature Medicine. 9: 1138-43. PMID 12897779 DOI: 10.1038/nm910  0.92
2003 Zander K, Sherman MP, Tessmer U, Bruns K, Wray V, Prechtel AT, Schubert E, Henklein P, Luban J, Neidleman J, Greene WC, Schubert U. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. The Journal of Biological Chemistry. 278: 43202-13. PMID 12881522 DOI: 10.1074/jbc.M305414200  0.92
2003 Berthoux L, Towers GJ, Gurer C, Salomoni P, Pandolfi PP, Luban J. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. Journal of Virology. 77: 3167-80. PMID 12584341 DOI: 10.1128/JVI.77.5.3167-3180.2003  0.92
2002 Ansari H, Greco G, Luban J. Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export. Molecular and Cellular Biology. 22: 6993-7003. PMID 12242280 DOI: 10.1128/MCB.22.20.6993-7003.2002  0.92
2002 Zhang YJ, Hatziioannou T, Zang T, Braaten D, Luban J, Goff SP, Bieniasz PD. Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. Journal of Virology. 76: 6332-43. PMID 12021366 DOI: 10.1128/JVI.76.12.6332-6343.2002  0.92
2002 Gurer C, Cimarelli A, Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. Journal of Virology. 76: 4666-70. PMID 11932435 DOI: 10.1128/JVI.76.9.4666-4670.2002  0.92
2001 Luban J. HIV-1 and ebola virus: The getaway driver nabbed Nature Medicine. 7: 1278-1280. PMID 11726960 DOI: 10.1038/nm1201-1278  0.92
2001 Cimarelli A, Luban J. Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation Journal of Virology. 75: 7193-7197. PMID 11435601 DOI: 10.1128/JVI.75.15.7193-7197.2001  0.92
2001 Braaten D, Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells Embo Journal. 20: 1300-1309. PMID 11250896 DOI: 10.1093/emboj/20.6.1300  0.92
2000 Colgan J, Asmal M, Luban J. Isolation, characterization and targeted disruption of mouse ppia: cyclophilin A is not essential for mammalian cell viability. Genomics. 68: 167-78. PMID 10964515 DOI: 10.1006/geno.2000.6295  0.92
2000 Cimarelli A, Luban J. Human immunodeficiency virus type 1 virion density is not determined by Nucleocapsid basic residues Journal of Virology. 74: 6734-6740. PMID 10888611 DOI: 10.1128/JVI.74.15.6734-6740.2000  0.92
2000 Cimarelli A, Sandin S, Höglund S, Luban J. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation Journal of Virology. 74: 4273-4283. PMID 10756042 DOI: 10.1128/JVI.74.9.4273-4283.2000  0.92
2000 Cimarelli A, Sandin S, Höglund S, Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA Journal of Virology. 74: 3046-3057. PMID 10708419 DOI: 10.1128/JVI.74.7.3046-3057.2000  0.92
1999 Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein Journal of Virology. 73: 8527-8540. PMID 10482606  0.92
1999 Cimarelli A, Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein Journal of Virology. 73: 5388-5401. PMID 10364286  0.92
1998 Yin L, Braaten D, Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels Journal of Virology. 72: 6430-6436. PMID 9658084  0.92
1998 Yin L, Boussard S, Allan J, Luban J. The HIV type 1 replication block in nonhuman primates is not explained by differences in cyclophilin a primary structure Aids Research and Human Retroviruses. 14: 95-97. PMID 9453257  0.92
1997 Re F, Luban J. HIV-1 Vpr: G2 cell cycle arrest, macrophages and nuclear transport Progress in Cell Cycle Research. 3: 21-27. PMID 9552403  0.92
1997 Braaten D, Ansari H, Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. Journal of Virology. 71: 2107-13. PMID 9032343  0.92
1996 Luban J. Absconding with the chaperone: Essential cyclophilin-gag interaction in HIV-1 virions Cell. 87: 1157-1159. PMID 8980222 DOI: 10.1016/S0092-8674(00)81811-5  0.92
1996 Braaten D, Wellington S, Warburton D, Luban J. Assignment of cyclophilin A (PPIA) to human chromosome band 7p13 by in situ hybridization Cytogenetics and Cell Genetics. 74: 262. PMID 8976380  0.92
1996 Franke EK, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction Virology. 222: 279-282. PMID 8806510 DOI: 10.1006/viro.1996.0421  0.92
1996 Braaten D, Aberham C, Franke EK, Yin L, Phares W, Luban J. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A Journal of Virology. 70: 5170-5176. PMID 8764025  0.92
1996 Colgan J, Yuan HEH, Franke EK, Luban J. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization Journal of Virology. 70: 4299-4310. PMID 8676452  0.92
1996 Braaten D, Franke EK, Luban J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and Simian immunodeficiency virus SIVCPZGAB but not group O HIV-1 or other primate immunodeficiency viruses Journal of Virology. 70: 4220-4227. PMID 8676442  0.92
1996 Braaten D, Franke EK, Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription Journal of Virology. 70: 3551-3560. PMID 8648689  0.92
1995 Luban J, Goff SP. The yeast two-hybrid system for studying protein-protein interactions. Current Opinion in Biotechnology. 6: 59-64. PMID 7894083 DOI: 10.1016/0958-1669(95)80010-7  0.92
1995 Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. Journal of Virology. 69: 642-50. PMID 7815527  0.92
1995 Franke EK, Luban J. Cyclophilin and Gag in HIV-1 replication and pathogenesis Advances in Experimental Medicine and Biology. 374: 217-228. PMID 7572395  0.92
1995 Franke EK, Chen BX, Tatsis I, Diamanduros A, Erlanger BF, Luban J. Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody Journal of Virology. 69: 5821-5823. PMID 7543589  0.92
1995 Re F, Braaten D, Franke EK, Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B Journal of Virology. 69: 6859-6864. PMID 7474100  0.92
1994 Luban J, Goff SP. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. Journal of Virology. 68: 3784-93. PMID 8189516  0.92
1994 Franke EK, Yuan HE, Bossolt KL, Goff SP, Luban J. Specificity and sequence requirements for interactions between various retroviral Gag proteins. Journal of Virology. 68: 5300-5. PMID 8035530  0.92
1994 Franke EK, Yuan HEH, Luban J. Specific incorporation of cyclophilin a into HIV-1 virions Nature. 372: 359-362. PMID 7969494  0.92
1994 Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 79: 119-30. PMID 7923370 DOI: 10.1016/0092-8674(94)90405-7  0.92
1993 Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73: 1067-78. PMID 8513493 DOI: 10.1016/0092-8674(93)90637-6  0.92
1993 Luban J, Lee C, Goff SP. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. Journal of Virology. 67: 3630-4. PMID 8497070  0.92
1993 Dorfman T, Luban J, Goff SP, Haseltine WA, Göttlinger HG. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. Journal of Virology. 67: 6159-69. PMID 8371356  0.92
1993 Berkowitz RD, Luban J, Goff SP. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. Journal of Virology. 67: 7190-200. PMID 8230441  0.92
1992 Luban J, Alin KB, Bossolt KL, Humaran T, Goff SP. Genetic assay for multimerization of retroviral gag polyproteins Journal of Virology. 66: 5157-5160. PMID 1629970  0.92
1991 Luban J, Goff SP. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein Journal of Virology. 65: 3203-3212. PMID 2033671  0.92
Show low-probability matches.